Viracept and Naprosyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viracept (nelfinavir mesylate) and Naprosyn (naproxen). Common drug interactions include acidosis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Viracept and Naprosyn. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

On Jul, 12, 2026

12 people who take Viracept and Naprosyn together, and have interactions are studied.

Viracept and Naprosyn drug interactions.

What are the common drug interactions of Viracept and Naprosyn, by gender? *:

female:

Acidosis (build-up of carbon dioxide in the blood)
Candiduria (candida in urine)
Hydronephrosis (water inside the kidney)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Nephrolithiasis (calculi in the kidneys)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Oedema peripheral (superficial swelling)
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Staphylococcus test positive

male:

Anxiety
Depression
Cough
Dyspnoea (difficult or laboured respiration)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hepatitis (inflammation of the liver)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Infection
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the common drug interactions of Viracept and Naprosyn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cough
Dyspnoea (difficult or laboured respiration)
Hepatitis (inflammation of the liver)
Hydronephrosis (water inside the kidney)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Infection
Kaposi's sarcoma (a tumour caused by human herpes virus)
Malaise (a feeling of general discomfort or uneasiness)
Nephrolithiasis (calculi in the kidneys)
Oedema peripheral (superficial swelling)

40-49:

n/a

50-59:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)

60+:

n/a

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Viracept and Naprosyn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously